Succinylcholine Chloride Injection, Solution
Product Images NDC 73043-021

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Succinylcholine Chloride (NDC 73043-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Devatis, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (20 mg/mL Vial Tray)

This is a pharmaceutical product information of a Multiple-dose Vials injection for Intravenous or Intramuscular Use containing succinylcholine chloride, with 20mg of chloride per 10mL dose. The injection is for medicinal use only and requires precautions and instructions for use, which are found in the package insert. The injection is manufactured by Deva Holding AS for Devatis, Inc. and can cause respiratory arrest and must be stored refrigerated.*

FDA Label Image

Structure (Structure)

FDA Label Image

Principal Display Panel (20 mg/mL Vial Label)

This is a description for a drug with the NDC code 73043-021-01, intended for intravenous or intramuscular use. It contains 0.18% KIP3593E01, methylparaben, and 0.02% succinylcholine piopyigaraben as preservatives. The drug should be stored at a temperature of 2° to 8°C and used with aseptic technique. It comes in a 10 mL multiple-dose vial distributed by SD:XECI‘Z,AZ;‘E CA92672. The drug is a paralyzing agent that causes respiratory arrest, and facilities for artificial respiration must be immediately available. The lot has an expiration date.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.